Please assess the completion status of the following clinical trial:

Trial Title: TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Couples with less than or equal to (\<= ) two failed fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) embryo transfer cycles~* Age greater than or equal to (\>=) 18 and \<= 40 years~* Body mass index (BMI): 18-30 kilogram per meter square (kg/m2)~* Normal uterine cavity under ultrasound~* Participant and her husband/partner must have read and signed the Informed Consent form (ICF)~* At least four normally fertilized oocytes (2Pronuclear stage (PN)) in the current cycle~Exclusion Criteria:~* Male with non-ejaculated sperm~* Participants with abnormal, undiagnosed gynecological bleeding or with genitourinary malformations~* Participants with any contraindication to Controlled Ovarian Stimulation (COS) for Assisted Reproductive Technologies (ART) or to gonadotropins~* Planned freeze all cycle (oocytes or embryos)~* Planned preimplantation genetic screening (PGS) or Pre-implantation genetic diagnosis (PGD) cycle~* Concurrent participation in another clinical study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- GERI+ Incubator (Type: ACTIVE_COMPARATOR): None
- Conventional incubator (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).